Cardiac


  • A headshot of Field Medical CEO Steven Mickelsen.
    Image attribution tooltip
    Permission granted by Field Medical
    Image attribution tooltip

    Field Medical raises $40M for PFA in ventricular tachycardia

    Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart rhythm disorder.

    By April 23, 2025
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit

    The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.

    By April 23, 2025
  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Intuitive, Boston Scientific and Edwards next up in medtech earnings

    Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and competitive dynamics in key markets.

    By April 21, 2025
  • The entrance to Illumina's San Diego campus.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    Illumina, Tempus AI partner to drive genomic testing beyond cancer

    The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing across all major diseases.

    By April 18, 2025
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s electrophysiology sales dip amid slow Varipulse start

    Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston Scientific in the red-hot pulsed field ablation market.

    By April 16, 2025
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards receives CE mark for Sapien M3 mitral valve replacement device

    The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s Mitraclip.

    By April 15, 2025
  • A person stands in front of the screen of a machine on wheels, near a sign that says "GE HealthCare"
    Image attribution tooltip
    Stringer via Getty Images
    Image attribution tooltip
    News roundup

    Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader

    Microbot reported positive data on its single-use endovascular robot. Elsewhere, GE Healthcare named a new business leader, and Puzzle Medical Devices raised $31 million.

    By April 10, 2025
  • A sign spelling Johnson & Johnson stands above a building.
    Image attribution tooltip
    BrasilNut1 via Getty Images
    Image attribution tooltip

    J&J starts IVL trial in ‘difficult-to-cross’ coronary arteries

    The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it emits waves from its tip.

    By April 8, 2025
  • A picture of a doctor looking at an X-ray screen during a procedure.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific’s Farapulse matches Medtronic cryoablation in trial

    Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.

    By April 3, 2025
  • Red human heart drawing on blue background
    Image attribution tooltip
    Jolygon via Getty Images
    Image attribution tooltip

    3 takeaways from ACC 2025

    Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

    By April 2, 2025
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott snags early CE mark for Volt PFA device

    With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market.

    By March 28, 2025
  • Abbott company sign outside
    Image attribution tooltip

    Courtesy of Abbott Laboratories

    Image attribution tooltip

    Abbott gets FDA nod to begin IVL trial after rivals buy up competition

    J&J acquired the IVL device maker Shockwave Medical last year for $13.1 billion, and Boston Scientific agreed to buy Bolt Medical in January for up to $664 million.

    By March 25, 2025
  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific leads $175M investment in 4C Medical

    The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in the U.S. and Europe.

    By March 6, 2025
  • A headshot of Field Medical CEO Steven Mickelsen.
    Image attribution tooltip
    Permission granted by Field Medical
    Image attribution tooltip
    Q&A

    Steven Mickelsen, Farapulse founder, eyes next frontier in pulsed field ablation

    Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool for ventricular tachycardia as CEO of startup Field Medical.

    By March 4, 2025
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    FDA recall notice details J&J pause of Varipulse

    Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after surgery.

    By March 3, 2025
  • Two doctors look at two computer screens that have medical images of a patient's brain.
    Image attribution tooltip
    Courtesy of Brainomix
    Image attribution tooltip

    Medtronic partners with Brainomix on AI stroke tool

    Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for interventions like TAVR.

    By Feb. 28, 2025
  • A white, rounded hourglass-shaped patch says "vitalconnect"
    Image attribution tooltip
    Courtesy of VitalConnect
    Image attribution tooltip

    VitalConnect raises $100M for heart monitor patch

    VitalConnect will use the money to commercialize the monitor, which detects arrhythmias and competes with patches from companies including iRhythm.

    By Feb. 21, 2025
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J resumes PFA cases, but analysts warn safety may hamper rollout

    J.P. Morgan analysts said the findings of J&J’s investigation “could significantly hinder the product’s rollout in the U.S. and globally” and lead doctors to “de-prioritize Varipulse.”

    By Feb. 18, 2025
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards predicts second-half lift from TAVR label expansion

    Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.

    By Feb. 12, 2025
  • FDA headquarters with sign in foreground
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts early alert about BD device linked to 30 injuries, 4 deaths

    The alert was posted one day after BD sent customers a letter warning about the risk of atherectomy catheters breaking.

    By Feb. 10, 2025
  • Recruitment or leadership concept. People row with spotlight highlighted one - creative visualization of people challenge competition
    Image attribution tooltip
    Getty Images via Getty Images
    Image attribution tooltip

    Pulse Biosciences names new CFO, continuing string of C-suite changes

    Pulse, which named a new CEO last month, is pitching its pulsed field ablation technology as a way to shorten procedure times.

    By Feb. 5, 2025
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific closes its year of PFA on a high note

    Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth quarter for the company’s electrophysiology group.

    By Feb. 5, 2025
  • A picture of the surgeon's console for Intuitive Surgical's da Vinci 5 surgical robot.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    2025 outlook

    Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty

    Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.

    By Jan. 31, 2025
  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    Getinge exits surgical perfusion, creating opportunity for Livanova

    Getinge CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced the company off the U.S. market in 2015.

    By Jan. 30, 2025
  • A picture of two people staring at the camera, one is leaning against a wall and one is sitting on a bench, in a white room.
    Image attribution tooltip
    Courtesy of Neko Health
    Image attribution tooltip

    Neko Health raises $260M to expand body scan service, fund R&D

    The company uses various medical devices to noninvasively check moles, the heart and more.

    By Jan. 28, 2025